Tweet This

Carrier

Broad term for health care companies that includes both insurance providers and health maintenance organizations (HMOs)

Biosimilars User Fee Act

Creates an abbreviated licensure pathway for biologic products that are demonstrated to be “biosimilar” to or “interchangeable” with an FDA-licensed biologic product. This pathway is…